Comparison of efficacy of the disease-specific LOX1- and constitutive cytomegalovirus-promoters in expressing interleukin 10 through adeno-associated virus 2/8 delivery in atherosclerotic mice.

The development of gene therapy vectors for treating diseases of the cardiovascular system continues at a steady pace. Moreover, in the field of gene therapy the utility of "disease-specific promoters" has strong appeal. Many therapeutic genes, including transforming growth factor beta 1 o...

Full description

Bibliographic Details
Main Authors: Hongqing Zhu, Maohua Cao, Leonardo Mirandola, Jose A Figueroa, Everardo Cobos, Maurizio Chiriva-Internati, Paul L Hermonat
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3988062?pdf=render

Similar Items